Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
GILD

Gilead

$81.82

1.03 (1.27%)

, ABBV

AbbVie

09:44
02/15/18
02/15
09:44
02/15/18
09:44
Periodicals
Lawmakers to push for hep C drug patents being taken, Capitol Forum says »

Representative Ro Khanna…

GILD

Gilead

$81.82

1.03 (1.27%)

ABBV

AbbVie

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 21

    Feb

  • 08

    Mar

Over a week ago
GLPG

Galapagos NV

$108.83

-0.88 (-0.80%)

, GILD

Gilead

$79.32

1.1 (1.41%)

10:00
02/12/18
02/12
10:00
02/12/18
10:00
Periodicals
Galapagos CEO said to be seeking protection against takeover, Bloomberg says »

Galapagos (GLPG) CEO Onno…

GLPG

Galapagos NV

$108.83

-0.88 (-0.80%)

GILD

Gilead

$79.32

1.1 (1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

GILD

Gilead

$79.32

1.1 (1.41%)

07:28
02/12/18
02/12
07:28
02/12/18
07:28
Conference/Events
Breaking Conference/Events news story on Gilead »

FDA PDUFA Date for Gilead…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

GILD

Gilead

$78.22

-4.54 (-5.49%)

09:13
02/09/18
02/09
09:13
02/09/18
09:13
Recommendations
Gilead analyst commentary at Wells Fargo »

Gilead should be bought…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

GILD

Gilead

$82.76

2.38 (2.96%)

, GSK

GlaxoSmithKline

09:23
02/08/18
02/08
09:23
02/08/18
09:23
Recommendations
Gilead, GlaxoSmithKline analyst commentary at Morgan Stanley »

Gilead Biktarvy approval,…

GILD

Gilead

$82.76

2.38 (2.96%)

GSK

GlaxoSmithKline

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

  • 25

    Mar

  • 23

    Apr

GSK

GlaxoSmithKline

$36.03

0.04 (0.11%)

, PFE

Pfizer

$34.98

-0.3 (-0.85%)

09:05
02/08/18
02/08
09:05
02/08/18
09:05
Hot Stocks
GlaxoSmithKline, Pfizer venture files patent infringement litigation against Gilead »

ViiV Healthcare, the…

GSK

GlaxoSmithKline

$36.03

0.04 (0.11%)

PFE

Pfizer

$34.98

-0.3 (-0.85%)

GILD

Gilead

$82.76

2.38 (2.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

  • 12

    Feb

  • 12

    Feb

  • 16

    Feb

  • 08

    Mar

  • 25

    Mar

  • 04

    Apr

  • 23

    Apr

BAC

Bank of America

$31.25

0.05 (0.16%)

, TWTR

Twitter

$26.91

1.67 (6.62%)

07:35
02/08/18
02/08
07:35
02/08/18
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

BAC

Bank of America

$31.25

0.05 (0.16%)

TWTR

Twitter

$26.91

1.67 (6.62%)

C

Citi

$74.99

0.17 (0.23%)

FCX

Freeport McMoRan

$17.86

-0.88 (-4.70%)

SNAP

Snap

$20.75

6.69 (47.58%)

GILD

Gilead

$82.76

2.38 (2.96%)

KO

Coca-Cola

$44.56

-0.11 (-0.25%)

PG

Procter & Gamble

$81.84

-0.54 (-0.66%)

NRG

NRG Energy

$25.36

-0.15 (-0.59%)

VLO

Valero

$89.84

-0.62 (-0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

  • 11

    Feb

  • 12

    Feb

  • 12

    Feb

  • 15

    Feb

  • 16

    Feb

  • 16

    Feb

  • 19

    Feb

  • 23

    Feb

  • 26

    Feb

  • 28

    Feb

  • 01

    Mar

  • 06

    Mar

  • 07

    Mar

  • 07

    Mar

  • 07

    Mar

  • 30

    May

GILD

Gilead

$80.38

2.01 (2.56%)

14:25
02/07/18
02/07
14:25
02/07/18
14:25
Hot Stocks
Gilead announces FDA approval of Biktarvy combo treatment for HIV-1 infection »

Gilead Sciences announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

GILD

Gilead

$80.38

2.01 (2.56%)

14:17
02/07/18
02/07
14:17
02/07/18
14:17
Hot Stocks
Gilead's Biktarvy HIV combo receives FDA approval »

Biktarvy is a three-drug…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

GILD

Gilead

$80.38

2.01 (2.56%)

10:40
02/07/18
02/07
10:40
02/07/18
10:40
Options
Notable call buying in Gilead Sciences after earnings »

Notable call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.